Thewjitcharoen, Y., Karndumri, K., Chatchomchuan, W., Porramatikul, S., Krittiyawong, S., Wanothayaroj, E., . . . Himathongkam, T. (2020). Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease. J Endocr Soc.
Citação norma ChicagoThewjitcharoen, Yotsapon, et al. "Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease." J Endocr Soc 2020.
Deismireacht MLAThewjitcharoen, Yotsapon, et al. "Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease." J Endocr Soc 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.